Market Research Logo

Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

  • Research Findings
  • Global - Pediatric (Infant) Vaccines Market and Forecast
  • Global - Pediatric (Infant) Vaccines Market Share and Forecast
    • Table Global - Pediatric (Infant) Vaccines Market Share (Percent), 2011 - 2016
    • Table Global - Forecast for Pediatric (Infant) Vaccines Market Share (Percent), 2017 - 2022
  • Global - Pediatric (Infant) Immunized and Forecast
  • Global - Pediatric (Infant) Immunized Share and Forecast
    • Table Global - Pediatric (Infant) Immunized Share (Percent), 2011 - 2016
    • Table Global - Forecast for Pediatric (Infant) Immunized Share (Percent), 2017 - 2022
  • Global - Doses of Pediatric (Infant) Vaccines Administered and Forecast
  • Global - Doses of Vaccines Administered to Pediatric (Infant) Share and Forecast
    • Table Global - Doses of Vaccines Administered to Pediatric (Infant) Share (Percent), 2011 - 2016
    • Table Global - Forecast for Doses of Vaccines Administered to Pediatric (Infant) Share (Percent), 2017 - 2022
  • Global - Vaccine Companies Market Share and Forecast
  • Disease wise - Vaccines Market and Forecast
    • Influenza - Pediatric (Infant) Vaccines Market and Forecast
    • MMR (Measles, Mumps, and Rubella Vaccine) - Pediatric Vaccines Market and Forecast
    • Pneumococcal - Pediatric Vaccines Market and Forecast
    • Meningococcal - Pediatric Vaccines Market and Forecast
    • Hepatitis - Pediatric Vaccines Market and Forecast
    • DTaP - Pediatric Vaccines Market and Forecast
    • Haemophilus Influenzae Type B (HIB) - Vaccines Market and Forecast
    • Combos (Combination) - Vaccines Market and Forecast
    • Polio - Vaccines Market and Forecast
    • Rotavirus - Vaccines Market and Forecast
    • Varicella - Vaccines Market and Forecast
  • Disease wise - Infants Immunized Numbers and Forecast
    • Influenza - Number of Infants Immunized and Forecast
    • MMR - Number of Pediatric (Infants) Immunized and Forecast
    • Pneumococcal - Number of Infants Immunized and Forecast
    • Meningococcal - Number of Infants Immunized and Forecast
    • Hepatitis - Number of Infants Immunized and Forecast
    • DTaP - Number of Infants Immunized and Forecast
    • Hib (Haemophilus Influenzae Type B) - Number of Infants Immunized and Forecast
    • Combos (Combination Vaccines) - Number of Infants Immunized and Forecast
    • Polio - Number of Infants Immunized and Forecast
    • Rotavirus - Number of Infants Immunized and Forecast
    • Varicella - Number of Infants Immunized and Forecast
  • Disease wise - Doses of Vaccines Administered and Forecast
    • Influenza - Doses of Infant Vaccines Administered and Forecast
    • MMR - Doses of Infant Vaccines Administered and Forecast
    • Pneumococcal - Doses of Infant Vaccines Administered and Forecast
    • Meningococcal - Doses of Infant Vaccines Administered and Forecast
    • Hepatitis - Doses of Infant Vaccines Administered and Forecast
    • DTaP - Doses of Infant Vaccines Administered and Forecast
    • Hib (Haemophilus Influenzae Type B) - Doses of Infant Vaccines Administered and Forecast
    • Polio - Doses of Infant Vaccines Administered and Forecast
    • Rotavirus - Doses of Infant Vaccines Administered and Forecast
    • Varicella - Doses of Infant Vaccines Administered and Forecast
  • Disease wise - Immunization Profile
    • Immunization Coverage (%) in Infants (2005 - 2015)
    • Global Immunization Profile (2011 - 2015)
      • Table Worldwide - Number of Reported Cases, 2011 - 2015
    • Regional Immunization Profile (2001 - 2015)
      • Measles - Number of Cases Reported
        • Table Measles - Number of Cases Reported, 2001 - 2015
      • Mumps - Number of Cases Reported
        • Table Mumps - Number of Cases Reported, 2001 - 2015
      • Rubella - Number of Cases Reported
        • Table Rubella - Number of Cases Reported, 2001 - 2015
      • Rubella (CRS) - Number of Cases Reported
        • Table Rubella (CRS) - Number of Cases Reported, 2001 - 2015
      • Diphtheria - Number of Cases Reported
        • Table Diphtheria - Number of Cases Reported, 2001 - 2015
      • Tetanus (Neonatal) - Number of Cases Reported
        • Table Tetanus (Neonatal) - Number of Cases Reported, 2001 - 2015
      • Tetanus (Total) - Number of Cases Reported
        • Table Tetanus (Total) - Number of Cases Reported, 2001 - 2015
      • Pertussis - Number of Cases Reported
        • Table Pertussis - Number of Cases Reported, 2001 - 2015
      • Polio - Number of Cases Reported
        • Table Polio - Number of Cases Reported, 2001 - 2015
      • Yellow Fever - Number of Cases Reported
        • Table Yellow Fever - Number of Cases Reported, 2001 - 2015
      • Japanese encephalitis - Number of Cases Reported, 2006 - 2015
        • Table Japanese encephalitis - Number of Cases Reported, 2006 - 2015
  • Vaccines Key Players Sales and Forecast
    • GlaxoSmithKline, plc.'s Vaccines Sales and Forecast
    • Merck & Co. Vaccines Sales and Forecast
    • Sanofi Pasteur's Vaccines Sales and Forecast
    • Pfizer, Inc.'s Vaccines Sales and Forecast
    • Others Vaccines Sales and Forecast
  • Vaccines - Products and Pipeline
    • GSK Vaccine Product Pipeline
    • Merck Vaccine Product Pipeline
      • Table Merck Vaccine Product Pipeline
    • Sanofi Vaccine Product Pipeline
      • Table Sanofi Vaccine Product Pipeline
    • Pfizer Vaccine Product Pipeline
      • Table Pfizer Vaccine Product Pipeline
  • Top Mergers and Acquisitions in the Vaccine Industry
    • Table Vaccine Mergers & Acquisitions
  • Vaccines and Regulator's Interventions
    • Making and Meeting Standards of Quality and Safety
    • Vaccine Funding
  • Vaccine Market Drivers
    • Inclusion in National Immunization Schedule
      • Table United States Immunization Schedule
      • Table Afghanistan Immunization Schedule
      • Table Norway Immunization Schedule
      • Table India Immunization Schedule
      • Table Vietnam Immunization Schedule
    • Growing Immunization Coverage for HPV Vaccines
    • Increase in Prevalence of Infectious Diseases
    • Global Immunization Vision and Strategy (GIVS)
    • GAVI Model Fuelling Vaccine Manufacturers
      • The Partnership Model
      • The Business Model
    • Increasing Vaccine Availability in United States
    • The Vaccine Safety Data link Project
    • The Vaccine Injury Compensation Program
    • Transforming of Vaccine Technologies
    • Global Vaccine Action Plan by WHO (2011 - 2020)
      • Table Worldwide - Total Future Deaths Averted through Vaccination (Million), 2011 - 2020
      • Table Goal-Level Indicators, 2015 & 2020
    • Continuous Focus on Effective Communication Strategies
      • Table Improvement Strategies or Requirements - the Joint Commission and the Project's Collaborating Organizations
  • Vaccines Market Challenges
    • Hurdles to Optimal use of Licensed Vaccines
      • Technical Obstacles
      • Economic Obstacles
      • Cultural Obstacles
    • Complexity of Vaccine Development & Approval System Thwarts Product Development
      • Legal Obstacles
      • General Technical Barriers
      • Economic Barriers
      • Regulatory Barriers
    • Shortening the Timeline for Vaccine Development
    • Refusal/Resistance to Vaccination
      • Vaccine Adverse Event Reporting System
    • Vaccine Shortages and Delays
    • Obstacles in Vaccine Research & Development
    • Barriers to New Entrants in the Vaccines Market

Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

Get 10% Free Customization in this Report

Global Pediatric Vaccines Market is expected to cross US$ 40 Billion by the year 2022. Our analysis found that the combination and pneumococcal vaccines was the two leading vaccines segment in 2017 and they continue to dominate the market in future years as well. The market of Combos (Combination vaccines) is thriving as most of the parents believed that if all these vaccines were given separately, than each child would have to take a large number of injections.

By the Year 2022, 500 Million Pediatrics will be get Immunization

Our research found that around 500 million infants get immunization by the year 2022 owing to rising concern against vaccine-preventable diseases and growing awareness. This report covers the past and present scenario and the growth prospects of the infants’ vaccine (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Polio, Haemophilus influenzae type B, Rotavirus, Varicella, Combination) Vaccines market across the world for the period of 2011-2022.

Globally 600 Million Doses of Vaccines will be Administrated in Pediatrics

Our study indicates that that around the globe nearly 600 million doses of vaccines will be administrated in infants by the year 2022 which will be nearly five times the number of influenza doses administered. The number of DTap doses administered in infants is forecast to increase over the years and will cross 50 Million by the year 2022. Report covers detailed information on all the 11 vaccines (Pneumococcal, Rotavirus, Meningococcal, DTap, MMR, Polio, Hepatitis, Varicella, Haemophilus influenzae type B, Influenza, Combination) Vaccines Doses of Vaccines Administered and Forecast.


Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis is the 2nd edition report published by Renub Research on Pediatric Vaccines. This 199 page market research report with 93 Figures and 30 Tables provides data and analysis on Global Pediatric Vaccines Market, Infants Immunized, Number of Vaccine Doses Administered in Pediatric (Infant) (Disease wise) & Key Players.

Vaccine Has Been Extensively Studied From 3 Major Points

1. Global Pediatric (Infant) Vaccines (Disease wise) Market & Forecast (2011 – 2022)
2. Pediatric (Infants) Immunized (Disease wise) & Forecast (2011 – 2022)
3. Doses of Vaccines Administered in Pediatric (Infant) (Disease wise) & Forecast (2011 – 2022)

11 Vaccines Studied in the Report are as Follows

1. Influenza
2. MMR (Measles, Mumps, and Rubella)
3. Pneumococcal
4. Meningococcal
5. Hepatitis
6. DTap (Diphtheria, Tetanus, Pertussis)
7. Haemophilus influenzae type B
8. Polio
9. Rotavirus
10. Varicella
11. Combination Vaccine

Companies Vaccines Sales and Forecast

1. GlaxoSmithKline, plc Sales & Forecast (2011 – 2022)
2. Merck & Co. Sales & Forecast (2011 – 2022)
3. Sanofi Pasteur’s Sales & Forecast (2011 – 2022)
4. Pfizer, Inc.’s Sales & Forecast (2011 – 2022)
5. Others Vaccines

Key Questions Answered In This Report

• What will be the market size of Global Pediatric Vaccine by the year 2022?
• What are the Key drivers for Pediatric Vaccines Market?
• What are the challenges to Infant Vaccines market?
• Who are the key players in Pediatric Vaccines market?
• What products are in key players Pipeline?


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;